Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04422210
Title A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Emory University Atlanta Georgia 30322 United States Details
Rigshospitalet; Onkologisk Klinik København Ø 2100 Denmark Details
Severance Hospital, Yonsei University Health System Seoul 03722 Korea, Republic of Details
ICO I Hospitalet Hospital Duran i Reynals Instituto Catalan de Oncologia de Hospitalet ICO L'Hospitalet de Llobregat Barcelona 08908 Spain Details
START Madrid. Centro Integral Oncologico Clara Campal; CIOCC Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field